文献速递中毒与环境急症复苏、休克与脓毒症

口服硫代硫酸钠与甘氨酸在大型猪口服氰化物中毒模型中的疗效

Efficacy of Oral Administration of Sodium Thiosulfate and Glycine in a Large, Swine Model of Oral Cyanide Toxicity.
PubMed 文献 · Ann Emerg Med · 2019-05-09
一句话结论在猪口服氰化物中毒模型中,口服硫代硫酸钠联合甘氨酸使60分钟生存率从0%提高到100%(P=.003)。

研究在9头45–55 kg猪中经口胃管给予氰化钾8 mg/kg,3分钟后治疗组经口胃管给予硫代硫酸钠508.2 mg/kg(3.25 M溶液)和甘氨酸30 mg/kg(3.5 M溶液)。主要终点60分钟生存率治疗组100% vs 对照组0%(P=.003)。研究结束时治疗组乳酸1.66 mmol/L vs 对照组9.43 mmol/L,平均动脉压治疗组81 mm Hg vs 对照组26 mm Hg,pH和氧饱和度也有显著差异。作者认为口服硫代硫酸钠联合甘氨酸在大型动物口服氰化物中毒模型中显著改善生存和生理指标。

要点

  • 猪口服氰化钾8 mg/kg后3分钟经口胃管给予硫代硫酸钠508.2 mg/kg(3.25 M)和甘氨酸30 mg/kg(3.5 M),60分钟生存率治疗组100% vs 对照组0%(P=.003)。
  • 研究结束时乳酸治疗组1.66 mmol/L(SD 0.82)vs 对照组9.43 mmol/L(SD 4.08),均值差7.69 mmol/L(95%CI -14.05至-1.32)。
  • 研究结束时平均动脉压治疗组81 mm Hg(SD 14)vs 对照组26 mm Hg(SD 6.7),均值差55.2 mm Hg(95%CI 37.8至72.6)。
  • 研究结束时pH和氧饱和度在治疗组与对照组之间也有显著差异。
  • 目前尚无FDA批准专门针对口服氰化物的解毒剂,口服能在胃肠道中和并阻止氰化物吸收的对策是需要的。

适用人群与场景

  • 大型动物(猪,45–55 kg)口服氰化物中毒模型,氰化钾8 mg/kg经口胃管一次推注。
  • 研究对象为镇静稳定后的猪,非人类急诊或ICU患者。

处置流程与药物剂量

  • 氰化钾8 mg/kg经口胃管一次推注后3分钟,治疗组经口胃管给予硫代硫酸钠508.2 mg/kg(3.25 M溶液)和甘氨酸30 mg/kg(3.5 M溶液)。

研究设计与关键结果

  • 研究类型为大型动物(猪)随机对照实验,9头猪(45–55 kg)镇静稳定后经口胃管给予氰化钾8 mg/kg,3分钟后治疗组经口胃管给予硫代硫酸钠508.2 mg/kg(3.25 M)和甘氨酸30 mg/kg(3.5 M)。
  • 主要终点60分钟生存率治疗组100% vs 对照组0%(P=.003,log-rank Mantel-Cox分析)。
  • 研究结束时(死亡或氰化物给药后60分钟)乳酸治疗组1.66 mmol/L(SD 0.82)vs 对照组9.43 mmol/L(SD 4.08),均值差7.69 mmol/L(SD 2.07,95%CI -14.05至-1.32)。
  • 研究结束时平均动脉压治疗组81 mm Hg(SD 14)vs 对照组26 mm Hg(SD 6.7),均值差55.2 mm Hg(SD 7.1,95%CI 37.8至72.6)。
  • 研究结束时pH和氧饱和度在治疗组与对照组之间也有显著差异。
  • 基线和治疗时所有动物相似。

证据类型、等级与局限

  • 证据类型:大型动物(猪)随机对照实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为口服硫代硫酸钠联合甘氨酸在大型动物口服氰化物中毒模型中显著改善生存和生理指标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Cyanide is a deadly poison, particularly with oral exposure, in which larger doses can occur before any symptoms develop. Multiple governmental agencies highlight oral cyanide as an agent that can be used in a terrorist attack because it can be easily weaponized and is readily available. Currently, there are no Food and Drug Administration-approved antidotes specifically for oral cyanide. An oral countermeasure that can neutralize and prevent absorption of cyanide from the gastrointestinal tract after oral exposure is needed. The objective of this study is to determine if the combination of glycine and sodium thiosulfate administered orally is effective in reducing mortality in a large, swine model of oral cyanide toxicity.

METHODS: Nine swine (45 to 55 kg) were instrumented, sedated, and stabilized. Potassium cyanide (at 8 mg/kg) in saline solution was delivered as a onetime bolus through an orogastric tube. Three minutes after cyanide administration, animals that were randomized to the treatment group received sodium thiosulfate (508.2 mg/kg, 3.25-M solution) and glycine (30 mg/kg, 3.5-M solution) through an orogastric tube. Survival at 60 minutes was the primary outcome. We compared survival between groups by log-rank Mantel-Cox analysis and trended laboratory results and vital signs.

RESULTS: At baseline and treatment, all animals were similar. Survival at 60 minutes was 100% in treated animals compared with 0% in the control group (P=.003). By the study end, defined as death or 60 minutes after cyanide administration, there was a significant difference in the lactate concentration between the treatment and control groups (control 9.43 mmol/L [SD 4.08]; treatment 1.66 mmol/L [SD 0.82]; difference between means 7.69 mmol/L [SD 2.07]; 95% confidence interval difference -14.05 to -1.32). Mean arterial pressure was significantly different between the treatment and control groups at study end (control 26 mm Hg [SD 6.7]; treatment 81 mm Hg [SD 14]; difference between means 55.2 mm Hg [SD 7.1]; 95% confidence interval difference 37.8 to 72.6). pH and oxygen saturation were also significantly different between the treatment and control groups at study end.

CONCLUSION: The combination of oral sodium thiosulfate and glycine significantly improved survival and physiologic parameters in a large-animal model of oral cyanide toxicity.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Ng PC, Hendry-Hofer TB, Witeof AE, et al. Efficacy of Oral Administration of Sodium Thiosulfate and Glycine in a Large, Swine Model of Oral Cyanide Toxicity. Ann Emerg Med. 2019. PMID: 31080026. doi:10.1016/j.annemergmed.2019.03.023

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。